Minoru Kurihara, MD | Authors

UFT Plus Cisplatin for Advanced Gastric Cancer

September 02, 1997

In a laboratory study using an experimental peritoneum model of gastrointestinal cancer, the UFTP [tegafur and uracil (UFT) plus cisplatin] regimen was shown to provide a survival benefit compared with the UFTM (UFT plus